Dollar cost averaging (DCA) in NAMS means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More NAMS Analysis
NAMS DCA Calculator
Dollar Cost Averaging — NewAmsterdam Pharma Company N.V.
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return+190.9%
Final Value$120.7K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return+178.1%
Final Value$115.4K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return+164.9%
Final Value$109.9K
Worst possible — still beats not investing
Best vs Worst gap26.0 pp
Your timing vs best-12.8%
Your timing vs worst+13.2%
If You Keep Investing…
Based on this stock's historical CAGR of 21.5%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$24K~1.3x your moneyfrom $18K invested
5 Years$50K~1.7x your moneyfrom $30K invested
10 Years$183K~3.1x your moneyfrom $60K invested
20 Years$1.5M~12.2x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.3x your money
5 Years~1.7x your money
10 Years~3.1x your money
20 Years~12.2x your money
$100/mo
$5K+$1K est. gain
$10K+$4K est. gain
$37K+$25K est. gain
$293K+$269K est. gain
$250/mo
$12K+$3K est. gain
$25K+$10K est. gain
$92K+$62K est. gain
$733K+$673K est. gain
$500/mo
$24K+$6K est. gain
$50K+$20K est. gain
$183K+$123K est. gain
$1.5M+$1.3M est. gain
$1,000/mo
$48K+$12K est. gain
$101K+$41K est. gain
$367K+$247K est. gain
$2.9M+$2.7M est. gain
* Projection assumes historical CAGR of 21.5% continues. Actual returns will vary.
Your DCA Results by Date
64 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Feb 9, 2021
$10.61
$10,000
$10,000
+0.00%
$0
Mar 9, 2021
$10.00
$10,500
$9,926
-5.47%
$-574
Apr 9, 2021
$10.14
$11,000
$10,562
-3.98%
$-438
May 10, 2021
$9.93
$11,500
$10,838
-5.76%
$-662
Jun 9, 2021
$9.85
$12,000
$11,256
-6.20%
$-744
Jul 9, 2021
$9.72
$12,500
$11,608
-7.14%
$-892
Aug 9, 2021
$9.72
$13,000
$12,108
-6.86%
$-892
Sep 9, 2021
$9.95
$13,500
$12,894
-4.49%
$-606
Oct 11, 2021
$9.82
$14,000
$13,226
-5.53%
$-774
Nov 9, 2021
$9.80
$14,500
$13,699
-5.53%
$-801
Dec 9, 2021
$9.84
$15,000
$14,255
-4.97%
$-745
Jan 10, 2022
$9.80
$15,500
$14,697
-5.18%
$-803
Feb 9, 2022
$9.79
$16,000
$15,182
-5.11%
$-818
Mar 9, 2022
$9.82
$16,500
$15,720
-4.72%
$-780
Apr 11, 2022
$9.85
$17,000
$16,277
-4.26%
$-723
May 9, 2022
$9.85
$17,500
$16,777
-4.13%
$-723
Jun 9, 2022
$9.90
$18,000
$17,362
-3.55%
$-638
Jul 11, 2022
$9.87
$18,500
$17,809
-3.73%
$-691
Aug 9, 2022
$9.91
$19,000
$18,381
-3.26%
$-619
Sep 9, 2022
$9.95
$19,500
$18,955
-2.79%
$-545
Oct 10, 2022
$9.97
$20,000
$19,494
-2.53%
$-506
Nov 9, 2022
$9.38
$20,500
$18,840
-8.10%
$-1,660
Dec 9, 2022
$9.40
$21,000
$19,380
-7.71%
$-1,620
Jan 9, 2023
$11.51
$21,500
$24,230
+12.70%
$2,730
Feb 9, 2023
$12.53
$22,000
$26,878
+22.17%
$4,878
Page 1 of 3
Frequently Asked Questions
Common questions about DCA investing in NAMS
Investing $500 per month in NewAmsterdam Pharma Company N.V. (NAMS) over the past 5 years would be worth approximately $115K today. That's +178.1% total return on $42K invested, with a +21.5% compound annual growth rate (CAGR).